Oops! It appears that you have disabled your Javascript. In order for you to see this page as it is meant to appear, we ask that you please re-enable your Javascript!

Type III-A CRISPR immunity promotes mutagenesis of staphylococci

  • 1.

    Polz, M. F., Alm, E. J. & Hanage, W. P. Horizontal gene transfer and the evolution of bacterial and archaeal population structure. Trends Genet. 29, 170–175 (2013).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  • 2.

    Marraffini, L. A. & Sontheimer, E. J. CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA. Science 322, 1843–1845 (2008).

    ADS  CAS  PubMed  PubMed Central  Article  Google Scholar 

  • 3.

    Barrangou, R. et al. CRISPR provides acquired resistance against viruses in prokaryotes. Science 315, 1709–1712 (2007).

    ADS  CAS  PubMed  Article  Google Scholar 

  • 4.

    Chen, J. S. et al. CRISPR–Cas12a target binding unleashes indiscriminate single-stranded DNase activity. Science 360, 436–439 (2018).

    ADS  CAS  PubMed  PubMed Central  Article  Google Scholar 

  • 5.

    Kazlauskiene, M., Tamulaitis, G., Kostiuk, G., Venclovas, Č. & Siksnys, V. Spatiotemporal control of type III-A CRISPR–CAS immunity: coupling DNA degradation with the target RNA recognition. Mol. Cell 62, 295–306 (2016).

    CAS  PubMed  Article  Google Scholar 

  • 6.

    Brouns, S. J. et al. Small CRISPR RNAs guide antiviral defense in prokaryotes. Science 321, 960–964 (2008).

    ADS  CAS  PubMed  PubMed Central  Article  Google Scholar 

  • 7.

    Tang, T. H. et al. Identification of novel non-coding RNAs as potential antisense regulators in the archaeon Sulfolobus solfataricus. Mol. Microbiol. 55, 469–481 (2005).

    CAS  PubMed  Article  Google Scholar 

  • 8.

    Garneau, J. E. et al. The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature 468, 67–71 (2010).

    ADS  CAS  PubMed  Article  Google Scholar 

  • 9.

    Hale, C. R. et al. RNA-guided RNA cleavage by a CRISPR RNA–Cas protein complex. Cell 139, 945–956 (2009).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  • 10.

    Makarova, K. S. et al. Evolutionary classification of CRISPR–Cas systems: a burst of class 2 and derived variants. Nat. Rev. Microbiol. 18, 67–83 (2020).

    CAS  PubMed  Article  Google Scholar 

  • 11.

    Goldberg, G. W., Jiang, W., Bikard, D. & Marraffini, L. A. Conditional tolerance of temperate phages via transcription-dependent CRISPR–Cas targeting. Nature 514, 633–637 (2014).

    ADS  CAS  PubMed  PubMed Central  Article  Google Scholar 

  • 12.

    Rostøl, J. T. & Marraffini, L. A. Non-specific degradation of transcripts promotes plasmid clearance during type III-A CRISPR–Cas immunity. Nat. Microbiol. 4, 656–662 (2019).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  • 13.

    Kazlauskiene, M., Kostiuk, G., Venclovas, Č., Tamulaitis, G. & Siksnys, V. A cyclic oligonucleotide signaling pathway in type III CRISPR–Cas systems. Science 357, 605–609 (2017).

    ADS  CAS  PubMed  Article  Google Scholar 

  • 14.

    Niewoehner, O. et al. Type III CRISPR–Cas systems produce cyclic oligoadenylate second messengers. Nature 548, 543–548 (2017).

    ADS  CAS  PubMed  Article  Google Scholar 

  • 15.

    Samai, P. et al. Co-transcriptional DNA and RNA cleavage during type III CRISPR–Cas Immunity. Cell 161, 1164–1174 (2015).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  • 16.

    Liu, T. Y., Liu, J. J., Aditham, A. J., Nogales, E. & Doudna, J. A. Target preference of type III-A CRISPR–Cas complexes at the transcription bubble. Nat. Commun. 10, 3001 (2019).

    ADS  PubMed  PubMed Central  Article  CAS  Google Scholar 

  • 17.

    Didier, J. P. et al. Impact of ciprofloxacin exposure on Staphylococcus aureus genomic alterations linked with emergence of rifampin resistance. Antimicrob. Agents Chemother. 55, 1946–1952 (2011).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  • 18.

    Rosche, W. A. & Foster, P. L. Determining mutation rates in bacterial populations. Methods 20, 4–17 (2000).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  • 19.

    El Meouche, I. & Dunlop, M. J. Heterogeneity in efflux pump expression predisposes antibiotic-resistant cells to mutation. Science 362, 686–690 (2018).

    ADS  CAS  PubMed  PubMed Central  Article  Google Scholar 

  • 20.

    Jiang, W., Samai, P. & Marraffini, L. A. Degradation of phage transcripts by CRISPR-associated RNases enables type III CRISPR–Cas immunity. Cell 164, 710–721 (2016).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  • 21.

    Luria, S. E. & Delbrück, M. Mutations of bacteria from virus sensitivity to virus resistance. Genetics 28, 491–511 (1943).

    CAS  PubMed  PubMed Central  Google Scholar 

  • 22.

    Gerrish, P. A simple formula for obtaining markedly improved mutation rate estimates. Genetics 180, 1773–1778 (2008).

    PubMed  PubMed Central  Article  Google Scholar 

  • 23.

    Maslowska, K. H., Makiela-Dzbenska, K. & Fijalkowska, I. J. The SOS system: a complex and tightly regulated response to DNA damage. Environ. Mol. Mutagen. 60, 368–384 (2019).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  • 24.

    Mo, C. Y. et al. Systematically altering bacterial SOS activity under stress reveals therapeutic strategies for potentiating antibiotics. mSphere 1, e00163-16 (2016).

    ADS  CAS  PubMed  PubMed Central  Article  Google Scholar 

  • 25.

    Slilaty, S. N. & Little, J. W. Lysine-156 and serine-119 are required for LexA repressor cleavage: a possible mechanism. Proc. Natl Acad. Sci. USA 84, 3987–3991 (1987).

    ADS  CAS  PubMed  Article  Google Scholar 

  • 26.

    Miller, J. H. & Low, K. B. Specificity of mutagenesis resulting from the induction of the SOS system in the absence of mutagenic treatment. Cell 37, 675–682 (1984).

    CAS  PubMed  Article  Google Scholar 

  • 27.

    Łobocka, M. et al. Genomics of staphylococcal Twort-like phages—potential therapeutics of the post-antibiotic era. Adv. Virus Res. 83, 143–216 (2012).

    PubMed  Article  CAS  Google Scholar 

  • 28.

    Ayora, S. et al. Double-strand break repair in bacteria: a view from Bacillus subtilis. FEMS Microbiol. Rev. 35, 1055–1081 (2011).

    CAS  PubMed  Article  Google Scholar 

  • 29.

    Cirz, R. T. et al. Inhibition of mutation and combating the evolution of antibiotic resistance. PLoS Biol. 3, e176 (2005).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  • 30.

    Pyenson, N. C., Gayvert, K., Varble, A., Elemento, O. & Marraffini, L. A. Broad targeting specificity during bacterial type III CRISPR–Cas immunity constrains viral escape. Cell Host Microbe 22, 343–353 (2017).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  • 31.

    Cao, L. et al. Identification and functional study of type III-A CRISPR–Cas systems in clinical isolates of Staphylococcus aureus. Int. J. Med. Microbiol. 306, 686–696 (2016).

    ADS  CAS  PubMed  Article  Google Scholar 

  • 32.

    Diep, B. A. et al. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 367, 731–739 (2006).

    CAS  PubMed  Article  Google Scholar 

  • 33.

    Denamur, E. et al. Intermediate mutation frequencies favor evolution of multidrug resistance in Escherichia coli. Genetics 171, 825–827 (2005).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  • 34.

    Wang, S., Wang, Y., Shen, J., Wu, Y. & Wu, C. Polymorphic mutation frequencies in clinical isolates of Staphylococcus aureus: the role of weak mutators in the development of fluoroquinolone resistance. FEMS Microbiol. Lett. 341, 13–17 (2013).

    CAS  PubMed  Article  Google Scholar 

  • 35.

    Silas, S. et al. Direct CRISPR spacer acquisition from RNA by a natural reverse transcriptase–Cas1 fusion protein. Science 351, aad4234 (2016).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  • 36.

    Harrington, L. B. et al. Programmed DNA destruction by miniature CRISPR–Cas14 enzymes. Science 362, 839–842 (2018).

    ADS  CAS  PubMed  PubMed Central  Article  Google Scholar 

  • 37.

    Gill, S. R. et al. Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. J. Bacteriol. 187, 2426–2438 (2005).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  • 38.

    Bae, T., Baba, T., Hiramatsu, K. & Schneewind, O. Prophages of Staphylococcus aureus Newman and their contribution to virulence. Mol. Microbiol. 62, 1035–1047 (2006).

    CAS  PubMed  Article  Google Scholar 

  • 39.

    Kreiswirth, B. N. et al. The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage. Nature 305, 709–712 (1983).

    ADS  CAS  PubMed  Article  Google Scholar 

  • 40.

    Horinouchi, S. & Weisblum, B. Nucleotide sequence and functional map of pC194, a plasmid that specifies inducible chloramphenicol resistance. J. Bacteriol. 150, 815–825 (1982).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  • 41.

    Khan, S. A. & Novick, R. P. Complete nucleotide sequence of pT181, a tetracycline-resistance plasmid from Staphylococcus aureus. Plasmid 10, 251–259 (1983).

    CAS  PubMed  Article  Google Scholar 

  • 42.

    Horinouchi, S. & Weisblum, B. Nucleotide sequence and functional map of pE194, a plasmid that specifies inducible resistance to macrolide, lincosamide, and streptogramin type B antibodies. J. Bacteriol. 150, 804–814 (1982).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  • 43.

    Morton, T. M., Johnston, J. L., Patterson, J. & Archer, G. L. Characterization of a conjugative staphylococcal mupirocin resistance plasmid. Antimicrob. Agents Chemother. 39, 1272–1280 (1995).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  • 44.

    Andrews, J. M. Determination of minimum inhibitory concentrations. J. Antimicrob. Chemother. 48 (Suppl 1), 5–16 (2001).

    CAS  PubMed  Article  Google Scholar 

  • 45.

    Kearse, M. et al. Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics 28, 1647–1649 (2012).

    PubMed  PubMed Central  Article  Google Scholar 

  • 46.

    Wichelhaus, T. A. et al. Biological cost of rifampin resistance from the perspective of Staphylococcus aureus. Antimicrob. Agents Chemother. 46, 3381–3385 (2002).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  • 47.

    Bae, T. & Schneewind, O. Allelic replacement in Staphylococcus aureus with inducible counter-selection. Plasmid 55, 58–63 (2006).

    CAS  PubMed  Article  Google Scholar 

  • 48.

    Cirz, R. T. et al. Complete and SOS-mediated response of Staphylococcus aureus to the antibiotic ciprofloxacin. J. Bacteriol. 189, 531–539 (2007).

    CAS  PubMed  Article  Google Scholar 

  • 49.

    Kennedy, S. et al. Detecting ultralow-frequency mutations by Duplex Sequencing. Nat. Protocols 9, 2586–2606 (2014).

    CAS  PubMed  Article  Google Scholar 

  • 50.

    Gibson, D. G. et al. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat. Methods 6, 343–345 (2009).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  • 51.

    Husmann, L. K., Scott, J. R., Lindahl, G. & Stenberg, L. Expression of the Arp protein, a member of the M protein family, is not sufficient to inhibit phagocytosis of Streptococcus pyogenes. Infect. Immun. 63, 345–348 (1995).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  • 52.

    Charpentier, E. et al. Novel cassette-based shuttle vector system for gram-positive bacteria. Appl. Environ. Microbiol. 70, 6076–6085 (2004).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  • 53.

    Bikard, D. et al. Exploiting CRISPR–Cas nucleases to produce sequence-specific antimicrobials. Nat. Biotechnol. 32, 1146–1150 (2014).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  • 54.

    Kinnevey, P. M. et al. Emergence of sequence type 779 methicillin-resistant Staphylococcus aureus harboring a novel pseudo staphylococcal cassette chromosome mec (SCCmec)-SCC-SCCCRISPR composite element in Irish hospitals. Antimicrob. Agents Chemother. 57, 524–531 (2013).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  • Leave a Reply

    Your email address will not be published. Required fields are marked *

    Top